BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24722574)

  • 1. Lubiprostone for chronic constipation in adults.
    Drug Ther Bull; 2014 Apr; 52(4):42-4. PubMed ID: 24722574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lubiprostone for treatment-resistant constipation associated with clozapine use.
    Meyer JM; Cummings MA
    Acta Psychiatr Scand; 2014 Jul; 130(1):71-2. PubMed ID: 24912951
    [No Abstract]   [Full Text] [Related]  

  • 4. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
    [No Abstract]   [Full Text] [Related]  

  • 5. Lubiprostone (Amitiza) for opioid-induced constipation.
    Med Lett Drugs Ther; 2013 Jun; 55(1418):47-8. PubMed ID: 24662842
    [No Abstract]   [Full Text] [Related]  

  • 6. Lubiprostone: a chloride channel activator for treatment of chronic constipation.
    Ambizas EM; Ginzburg R
    Ann Pharmacother; 2007 Jun; 41(6):957-64. PubMed ID: 17519292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lubiprostone: chloride channel activator for chronic constipation.
    Rivkin A; Chagan L
    Clin Ther; 2006 Dec; 28(12):2008-21. PubMed ID: 17296458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lubiprostone: RU 0211, SPI 0211.
    Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Saad R; Chey WD
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):497-508. PubMed ID: 19072397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lubiprostone (amitiza) for chronic constipation.
    Med Lett Drugs Ther; 2006 Jun; 48(1236):47-8. PubMed ID: 16770297
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series.
    O'Brien CE; Anderson PJ; Stowe CD
    Ann Pharmacother; 2010 Mar; 44(3):577-81. PubMed ID: 20179256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.
    Lembo AJ; Johanson JF; Parkman HP; Rao SS; Miner PB; Ueno R
    Dig Dis Sci; 2011 Sep; 56(9):2639-45. PubMed ID: 21769655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubiprostone: viewpoints.
    Schiller LR; Camilleri M
    Drugs; 2006; 66(6):880-1. PubMed ID: 16706563
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.
    Ginzburg R; Ambizas EM
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lubiprostone.
    McKeage K; Plosker GL; Siddiqui MA
    Drugs; 2006; 66(6):873-9. PubMed ID: 16706562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lubiprostone.
    Winpenny JP
    IDrugs; 2005 May; 8(5):416-22. PubMed ID: 15883925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation.
    Crowell MD; Harris LA; DiBaise JK; Olden KW
    Curr Opin Investig Drugs; 2007 Jan; 8(1):66-70. PubMed ID: 17263187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lubiprostone: a chloride channel activator.
    Lacy BE; Levy LC
    J Clin Gastroenterol; 2007 Apr; 41(4):345-51. PubMed ID: 17413599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.
    Johanson JF; Ueno R
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1351-61. PubMed ID: 17509103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
    Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
    Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.